Safety Policies & Visitor Guidelines |
Appointments & Scheduling |
Schedule a COVID vaccine appointment:
call us 8am to 5pm, Monday through Friday, at 267-758-4902.
Adults (18-65), Geriatrics (65+)
English and Dutch
Adults (18-65), Geriatrics (65+)
English and Dutch
Perelman Center for Advanced Medicine
West Pavilion, 2nd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Timothy J Brown, Benjamin Karasic, Charles Schneider, Ursina Teitelbaum, Kim Reiss, Tara Mitchell, Ryan Massa, Mark O'Hara, Lisa DiCicco, Luis Garcia-Marcano, Ravi Amaravadi, Peter O'Dwyer: Phase I Trial of Regorafenib, Hydroxychloroquine and Entinostat in Metastatic Colorectal Cancer ASCO 2021, Chicago, IL : 2021.
Kim A. Reiss, MD; Rosemarie Mick, MS; Mark H. O’Hara, MD; Ursina Teitelbaum, MD; Thomas B. Karasic, MD; Charles Schneider, MD; Stacy Cowden, RN; Traci Southwell, RN; Janae Romeo, MBE; Natallia Izgur, RN; Zain M. Hannan, BA; Rashmi Tondon, MD; Katharine Nathanson, MD; Robert H. Vonderheide, MD, DPhil; Max M. Wattenberg, MD; Gregory Beatty, MD, PhD; Susan M. Domchek, MD: A Phase II Study of Maintenance Rucaparib in Patients with Platinum Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2 or PALB2
Journal of Clinical Oncology : 2021.
Kim A. Reiss and Robert H. Vonderheide: Alternatives to Perpetual Chemotherapy for Metastatic Pancreatic Cancer Clinical Cancer Research : 2021.
Shun Yu, MD; Ronac Mamtani, MD, MSCE1; Mark H. O’Hara, MD; Peter J. O’Dwyer, MD; Ofer Margalit, MD; Bruce J. Giantonio, MD; Einat Shmueli, MD, Kim A. Reiss, MD* and Ben Boursi, MD1*, *Authors contributed equally: Comparative effectiveness of total neoadjuvant therapy versus standard adjuvant chemotherapy for locally advanced rectal cancer Clinical Colorectal Cancer : 2021.
Ofer Margalit; Einat Shacham-Shmueli; Yu-Xiao Yang; Yaacov R. Lawerence; Kim A. Reiss; Talia Golan; Naama Halpern; Dan Aderka; Bruce Giantonio ; Ronac Mamtani; and Ben Boursi: Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric Adenocarcinoma The Oncologist : 2021.
Zain Hannan, BA; Shun Yu, MD; Susan Domchek, MD; Ronac Mamtani, MD; Kim A. Reiss, MD: Clinical Characteristics of Patients with Pancreatic Cancer and Pathogenic ATM Alterations JNCI Cancer Spectrum : 2021.
Jada G. Hamilton, PhD, MPH; Heather Symecko, MPH; Kelsey Spielman, MS, CGC; Kelsey Breen, MS, MSc, CGC; Rebecca Mueller, MS, CGC; Amanda Catchings, MS, CGC; Magan Trottier, MSc, MSc, CGC; Erin E. Salo-Mullen, MS, MPH, CGC; Ibrahim Shah, BA; Anna Arutyunova, BS; Melissa Batson, MPH; Rebecca Gebert, BA; Stacy Pundock, BA; Elizabeth Schofield, MPH 1, Kenneth Offit, MD, MPH; Zsofia K. Stadler, MD; Karen Cadoo, MD; Maria I. Carlo, MD; Vivek Narayan, MD; Kim A. Reiss, MD; Mark E. Robson, MD; Susan M. Domchek, MD: Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer Genetics in Medicine : 2021.
W. Tristram Arscott, M.D, Kevin T. Nead, M.D, M.Phil, Adham Bear, M.D., Sriram Venigalla, M.D., Jacob Shabason, M.D., J. Nickolas Lukens, M.D., John P. Plastaras, M.D./Ph.D., Andrzej Wojcieszynski, M.D., James Metz, M.D., Mark O’Hara, M.D., Kim A. Reiss, M.D., Ursina Teitelbaum, M.D., Arturo Loaiza-Bonilla, M.D, Jeffrey Drebin, M.D., Major Kenneth Lee, IV, M.D./Ph.D, Stuti G. Shroff, M.D./Ph.D., Edgar Ben-Josef, M.D.: Concurrent Nab-Paclitaxel and Radiotherapy - Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer American Journal of Clinical Oncology : 2021.
Kim A. Reiss1; Max M. Wattenberg; Nevena Damjanov; Elizabeth P. Dunphy; Mona Jacobs-Small; M. Judy Lubas; James Robinson; Lisa Dicicco; Luis Garcia-Marcano; Michael A. Giannone;Thomas Karasic; Emma E. Furth; Erica Carpenter; Andrzej Wojcieszynski; Robert H. Vonderheide; Gregory L. Beatty; Edgar Ben-Josef: A Pilot Study of Galunisertib Plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma Mol Cancer Ther
Erin M. Bange MD, Abigail Doucette MPH, Peter E. Gabriel. MD MS, Florence Porterfield, James J. Harrigan MD PharmD, Robin Wang, Andrez P. Wojcieszynski MD, Ben Boursi MD, 2, Bethany I. Mooney CRNP, Kim A. Reiss, MD*, Ronac Mamtani MD MSCE*: Opportunity costs of receiving palliative chemotherapy for metastatic pancreatic ductal adenocarcinoma JCO Oncol Pract
16 (8): e678-e687,2020.
Division of Hematology OncologyPerelman Center for Advanced Medicine10th Floor, South PavilionOffice #10-3053400 Civic Center Blvd
Patient appointments: 800-789-7366